Jun 27 |
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
|
Jun 24 |
Akebia Therapeutics names Erik Ostrowski as CFO
|
Jun 24 |
Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer
|
Jun 21 |
Further weakness as Akebia Therapeutics (NASDAQ:AKBA) drops 16% this week, taking five-year losses to 80%
|
May 23 |
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference
|
May 14 |
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference
|
May 11 |
Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA)
|
May 10 |
Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview
|
May 10 |
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript
|
May 10 |
Akebia Therapeutics First Quarter 2024 Earnings: Misses Expectations
|